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Abstract
Probes are essential to visualize proteins in their cellular environment, both using light microscopy as well as electron 
microscopy (EM). Correlated light microscopy and electron microscopy (CLEM) requires probes that can be imaged simul-
taneously by both optical and electron-dense signals. Existing combinatorial probes often have impaired efficiency, need 
ectopic expression as a fusion protein, or do not target endogenous proteins. Here, we present FLIPPER-bodies to label 
endogenous proteins for CLEM. Fluorescent Indicator and Peroxidase for Precipitation with EM Resolution (FLIPPER), the 
combination of a fluorescent protein and a peroxidase, is fused to a nanobody against a target of interest. The modular nature 
of these probes allows an easy exchange of components to change its target or color. A general FLIPPER-body targeting GFP 
highlights histone2B-GFP both in fluorescence and in EM. Similarly, endogenous EGF receptors and HER2 are visualized 
at nm-scale resolution in ultrastructural context. The small and flexible FLIPPER-body outperforms IgG-based immuno-
labeling, likely by better reaching the epitopes. Given the modular domains and possibilities of nanobody generation for 
other targets, FLIPPER-bodies have high potential to become a universal tool to identify proteins in immuno-CLEM with 
increased sensitivity compared to current approaches.
Keywords Probes · Correlated microscopy · FLIPPER · Nanobody · APEX2
Introduction
An ultimate goal in microscopy is to detect targets at both 
the fluorescent level, opening the possibilities to study live 
cells and investigate large areas, as well as detection using 
electron microscopy (EM) to allow localization with molec-
ular precision (nanometer range) in the context of ultra-
structure. These benefits are all combined in correlated light 
microscopy (LM) and EM [CLEM; reviewed in (de Boer 
et al. 2015; Loussert Fonta and Humbel 2015)]. In CLEM 
probes, both the fluorescent and electron-dense signal need 
to be specifically targeted to the protein of interest.
Specific probe targeting for endogenous proteins is usu-
ally done with antibodies, which can be applied before (pre-
embedding) or after EM preparation (post-embedding). 
The advantage of post-embedding labeling is the preserved 
ultra-structure, but antigen binding is impaired due to EM 
preparation. Pre-embedding labeling has a compromised 
ultra-structure partly as a result of the permeabilization, but 
a good accessibility to the antigens (de Boer et al. 2015; 
Schnell et al. 2012). Another disadvantage of antibodies 
is their size: 150 kDa with a length of 14 nm for typical 
IgG (Fig. 1a). This size results in a distance up to 28 nm 
between target and label (Mikhaylova et al. 2015; Muylder-
mans 2013).
Nanobody-mediated targeting reduces the distance of 
target and probe. Nanobodies are the smallest antigen-
binding proteins that are derived from heavy-chain anti-
bodies of Camelidea species, consisting of a single chain, 
as opposed to IgGs (Hamers-Casterman et al. 1993; Helma 
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et al. 2015). Genetic fusion of nanobodies with fluores-
cent proteins [FPs; chromobodies (Rothbauer et al. 2006)], 
as well as with ascorbate peroxidase 2 (APEX2) for EM 
visualization (Ariotti et al. 2015) have been used in co-
expression systems and successfully show identification of 
several targets. However, co-expression in cells also affects 
protein function for some targets [(Helma et al. 2015); 
see below]. Indirect EM labeling using an anti-nanobody 
antibody and a protein-A conjugated to gold particles was 
recently pioneered, but still results in a relatively large dis-
tance, > 17 nm, from the gold particle to the target protein 
(HER2) (Kijanka et al. 2017). We reasoned that a single 
multi-domain protein that (1) can specifically target pro-
teins based on a nanobody; (2) directly visualizes these 
using fluorescent proteins; and (3) identifies targets in EM 
using peroxidase-mediated DAB precipitation may have 
better labeling efficiency than particle-based detection 
in EM. Since the architecture of the genetically-encoded 
probes allows easy domain swapping, virtually unlimited 
combinations between targeting modules, FPs and per-
oxidase can be made (Fig. 1b). Note that, as opposed to 
most current genetically-encoded probes, our FLIPPER-
bodies are first secreted by producer cells and subsequently 
used, either as a supernatant or purified, like hybridoma 
generated monoclonal antibodies. Our results show that 
this protein-based probe highly efficiently labels targets, 
including in difficult to reach subcellular areas, and out-
performs current available alternatives.
Methods
Plasmids
The sequences of the used FLIPPER-bodies are presented 
(Supplementary data). The backbones of the FLIPPER-
bodies were ordered by Eurofins Genomics (Ebersberg, 
Germany) and modules were switched with standard 
molecular cloning tools. The signal peptide originated 
from EpCAM. The cDNA of mCherry and dTomato [gifts 
from Roger Tsien; (Shaner et al. 2004)] were inserted 
using BamHI and EcoRI. Horseradish peroxidase (HRP) 
was replaced by APEX2 [gift from Alice Ting: Addgene 
plasmid # 49385; (Lam et al. 2015)] using EcoRI and NotI. 
Anti-EGFR (epidermal growth factor receptor) nanobody 
was replaced by anti-HER2 (Human Epidermal growth 
factor Receptor 2) using AgeI and EcoRI. Other plas-
mids used were EGFR-GFP [gift from Alexander Sorkin: 
Addgene plasmid # 32751; (Carter and Sorkin 1998)], 
Histone2B (H2B)-GFP [gift from Geoff Wahl: Addgene 
plasmid # 11680 (Kanda et al. 1998)] and SP-His6-GPI-
CFP (Hauser and Tsien 2007).
Cell culture and transfection
HEK293T, A431, and SkBr3 cells were cultured in DMEM 
(Invitrogen), and CHO-K1 cells were cultured in DMEM/
Ham’s F-12 1:1 (Lonza), all supplemented with 5% Fetal 
Bovine Serum (FBS, Greiner) and penicillin/streptomycin 
(PAA) at 37 °C in the presence of 5%  CO2. Cells were 
transfected using 1:4 DNA/polyethylenimine 1 mg/ml (PEI 
MW 25,000, Polysciences). Stable CHO-K1 cell lines pro-
ducing anti-GFP and anti-EGFR FLIPPER-bodies were 
selected using 1 mg/ml G418 (Invitrogen) and subsequent 
FACS-sorted (MoFlo Astrios, Central Flowcytometry 
Unit, UMCG). For imaging, HEK293T and A431 cells 
were grown on glass bottom dishes (Greiner); SkBr3 cells 
were grown on gridded glass bottom dishes (MatTek).
Fixation
The cells were fixed by adding dropwise an equal volume 
of 2% paraformaldehyde/0.2% glutaraldehyde in 0.1 M 
sodium cacodylate buffer pH 7.4 to the medium. After 
10 min, the medium/fixative was replaced by the fixa-
tive described above for 30 min and rinsed once 5 min 
with 0.1 M sodium cacodylate buffer and twice 5 min 
with Phosphate Buffered Saline (PBS) pH 7.3. HEK293T 
expressing H2B-GFP was permeabilized with 0.1% Triton 
Fig. 1  Small FLIPPER-bodies for single-step CLEM labeling. a 
Left: traditional indirect antibody labeling conjugated with QD, rep-
resented by black dot. Right: a single-labeling step with FLIPPER-
body. Black circle represents DAB conversion. Black triangle: 
antigen. Bar 2  nm. Adapted from (Beghein and Gettemans 2017; 
Giepmans et al. 2006; Martell et al. 2012). b Boxes representing the 
modules of the anti-GFP and anti-EGFR FLIPPER-bodies. The boxes 
are shown in proportion to each other. Signal peptide (#), His6-tag 
(*), thrombin cleavage site (^), mCherry (mCh), dTomato (dTom), 
horseradish peroxidase (HRP), ascorbate peroxidase 2 (APEX2), anti-
GFP nanobody (anti-GFP), anti-EGFR nanobody (anti-EGFR)
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X-100 in PBS for 7 min and washed three times 5 min with 
PBS. All steps were performed at R.T.
FLIPPER‑body production
FLIPPER-bodies are produced and secreted by stable CHO 
cells or by transiently transfected HEK293T cells. Condi-
tioned media were collected after 2 days of culturing. The 
activity of the secreted peroxidase was tested as a 1:1 mix-
ture of medium and diaminobenzidine (DAB, 5 mg DAB in 
10 ml PBS, filtered through Whatman 0.2 μm filter with an 
additional 3 μl of 30%  H2O2).
Antibodies
Primary antibodies used were rabbit anti-GFP (Rockland, 
600-401-215, 1:200) and mouse anti-EGFR (Santa Cruz, 
sc120, 1:200). Secondary antibodies used were goat anti-
mouse Alexa Fluor 546 (Invitrogen, A11030, 1:500), donkey 
anti-rabbit Alexa Fluor 594 (Invitrogen, A21207, 1:500), 
goat anti-mouse quantum dot (QD) 655 (Life Technologies, 
Q11021MP, 1:500), goat anti-rabbit QD655 (Life tech-
nologies, Q11421MP, 1:500), sheep anti-mouse HRP (GE-
Healthcare, NA931V, 1:500), donkey anti-rabbit HRP (GE-
Healthcare, NA934V, 1:500), goat anti-mouse 10 nm gold 
(BBI solutions, EM.GMHL10, 1:50), and goat anti-rabbit 
10 nm gold (BBI solutions, EM.GAR10, 1:50).
Immuno‑labeling, confocal microscopy
HEK293T, A431, and SkBr3 cells were labeled with FLIP-
PER-bodies for 45 min and rinsed twice 5 min with PBS. 
Primary and secondary antibodies were diluted in 1% BSA/
PBS and followed by rinsing three times with PBS. Next, the 
cells were incubated with Hoechst (Sigma-Aldrich, 861405, 
1 µg/ml), for 10 min, except H2B-GFP labeled with QDs, 
and rinsed three times 5 min with PBS. All steps were per-
formed at room temperature. Fluorescent images were gener-
ated using confocal imaging (Zeiss LSM 780, Plan-Neofluar 
63×/N.A. 1.3 Imm Korr DIC M27 lens).
DAB polymerization, embedding, electron 
microscopy
DAB (5 mg DAB in 10 ml PBS, filtered through What-
man 0.2 μm filter with an additional 3 μl of 30%  H2O2) 
was added to the cells for 15 min. Afterward, the cells were 
rinsed twice for 5 min with PBS. Samples were prepared for 
EM as described previously (Kuipers et al. 2015b). In short, 
the cells were post-fixed with 1%  OsO4 in 0.1 M sodium 
cacodylate buffer and dehydrated with an increasing ethanol 
series. Finally, the cells were embedded in EPON. The glass 
bottom was removed using hydrogen fluoride for 10 min.
Ultrathin sections (80 nm) were obtained and collected 
at 150 mesh copper grids. Sections were not contrasted 
with uranyl or lead. The samples were pre-irradiated using 
FEI CM100 TEM to stabilize them in the electron beam 
and images were recorded using a Zeiss Supra55 scanning 
microscope (Kuipers et al. 2015a; Sokol et al. 2015). STEM 
images were taken with 2.5 nm pixel size at 28 KV. All data 
are available at http://www.nanotomy.org.
CLEM workflow
For all experiments, cells were fixed and labeled, either with 
or without permeabilization. Fluorescence microscopy was 
performed at the wet, fixed samples. Subsequently, the DAB 
precipitates were formed and cells were processed for EM, 
using osmium fixation and epon embedding. While this pro-
cedure leads to loss of fluorescence, reviewed in de Boer 
et al. (2015), the FLIPPER-bodies allow identification of the 
targets at the nanometer-range scale by analysis of osmio-
philic DAB polymers. For a more complete flow chart of 
alternative labeling procures, see de Boer et al. (2015).
Results
Previously, we introduced the combination of FP and HRP 
linked to a protein of interest as a probe for CLEM inside 
cells, named FLIPPER (Kuipers et al. 2015b). In addition, 
APEX2 (Lam et al. 2015) is used to generate the EM-detect-
able signal. FLIPPER-bodies are multi-modular fusions 
between a nanobody, an FP and a peroxidase (Fig. 1b). 
Because of the inclusion of a signal peptide, the FLIPPER-
body is secreted by producer cells and the conditioned media 
is used to label other cells. Alternatively, using the included 
His-tag, the FLIPPER-bodies can be purified. The different 
FLIPPER-bodies below were all produced by mammalian 
cells. As a first test for expression and activity, the medium 
was simply tested for DAB conversion (Fig. S1).
FLIPPER‑bodies visualize nucleus‑localized GFP 
at the LM and EM levels
As a proof-of-concept, a FLIPPER-body was created con-
sisting of a nanobody targeting GFP fused to mCherry and 
HRP. After fixation and permeabilization H2B-GFP positive 
cells were labeled directly with an anti-GFP FLIPPER-body 
only or as a control an anti-GFP IgG that was detected with 
a secondary antibody conjugated to QD655, another CLEM 
probe for immuno-labeling [(Nisman et al. 2004; Giepmans 
et al. 2005); Fig. 2]. H2B-GFP expression is clearly visible 
in the nucleus, while the limited penetration of the QDs can 
be seen by detection of some QDs in the cytoplasm and 
not in the nucleus (Fig. 2a). None of the other secondary 
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antibodies conjugated to either Alexa594, HRP, or 10-nm 
gold particles could be discerned in the nucleus either (Fig. 
S2). In contrast, the FLIPPER-body labeling shows in GFP 
positive nuclei both a mCherry signal and the electron-dense 
signal derived from DAB conversion (Fig. 2b). Note that 
the signal is found in the H2B-GFP-transfected cells only. 
These results demonstrate the functionality of FLIPPER-
bodies for intranuclear labeling of proteins, as well as the 
feasibility to target GFP. Therefore, we set out if we can use 
FLIPPER-bodies as generic tools, starting with targeting a 
cell surface receptor.
Specific labeling of the EGFR by FLIPPER‑bodies
EGFR was chosen as the second target to optimize and ver-
ify FLIPPER-body technology. The new probe, consisting of 
a well-characterized anti-EGFR nanobody (7D12; Roovers 
et al. 2011), was positioned at the N-terminal of the FP and 
APEX2 modules (Fig. 1b). We switched the order, because 
binding capacity of the nanobody was lost after C-termi-
nal conjugation. dTomato was chosen as FP because of its 
dimer-forming capacity that may double the fluorescence 
and EM signals.
EGFR-GFP overexpressing cells were targeted with tra-
ditional immuno-CLEM using IgGs and QDs as described 
above, as well as with anti-EGFR FLIPPER-body by pre-
embedding labeling using non-permeabilized cells. The 
EGFR-GFP signal is present in the Golgi system as well as 
on the plasma membrane of the cells (Fig. 3). Traditional 
labeling clearly revealed QD fluorescence at the apical 
plasma membrane, but significantly less at cell–cell con-
tact sites (Fig. 3a). Secondary antibodies conjugated with 
other labels showed similar results (Fig. S3). FLIPPER-
body-mediated labeling of EGFR was clearly visible by the 
dTomato signal as well as by the electron-dense staining 
(Fig. 3b). Note that the signal was distributed evenly over the 
surface of the cells, including at sites of cell–cell contacts 
that were not visualized with the traditional methods.
Endogenous detection of EGFR
Next, we used A431 cells, known for its high EGFR levels 
(Haigler et al. 1978), to investigate our FLIPPER-body 
Fig. 2  FLIPPER-body labeling of nuclear localized GFP. HEK293T 
cells expressing H2B-GFP. a H2B-GFP was detected by indirect labe-
ling with rabbit anti-GFP and secondary IgG conjugated to QD655. 
Note that fluorescence detection of QDs is limited to the cytoplasm, 
which may be non-specific labeling. High-resolution EM images also 
show only QDs in the cytoplasm. b H2B-GFP was detected by direct 
labeling with FLIPPER-bodies containing mCherry. The used FLIP-
PER-body is shown at the right. Note the specificity of the mCherry 
signal in only the GFP positive cells. With EM, the black DAB pre-
cipitates are seen in the nuclei. DIC differential interference contrast, 
GFP GFP fluorescence, QD655 QD655 fluorescence, mCherry FLIP-
PER-body, merged GFP and mCherry, EM ultrathin EM section. Bars 
LM and EM 10 µm, EM zoom in 1 µm. Unbiased large-scale high-
resolution EM images are available via http://www.nanotomy.org
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technology for detection of endogenous proteins. The 
A431 cells were fixed and labeled with the different 
probes. Indirect labeling of EGFR using QDs resulted in 
a labeling of the periphery of the cell clusters, while the 
cell–cell contacts were devoid of any labeling (Fig. 4a). 
The decreased labeling efficiency at cell–cell contact sites 
was also seen using IgGs with other labels, even with the 
small moiety Alexa546 (Fig. S4). Labeling efficiency of 
the EGFR was much higher with anti-EGFR FLIPPER-
body (Fig. 4b). Not only the periphery of the cell clusters 
was labeled with high efficiency using as assessed by dTo-
mato fluorescence and electron-dense precipitates for LM 
and EM, respectively, but also the cell–cell contacts sites 
also have efficient labeling.
A third target: HER2 detection with correlated 
microscopy
FLIPPER-bodies targeting HER2 were created by switch-
ing the anti-EGFR nanobody for an anti-HER2 nanobody 
(11A4). The HER2 nanobody was well characterized 
in binding capacity and specificity (Kijanka et al. 2013). 
HER2 is known for its high expression level in breast cancer 
(Yarden 2001); therefore, the breast cancer cell line SkBr3 
was labeled. HER2 detection with FLIPPER-bodies shows 
high label efficiency in both modalities (Fig. 5a), as empha-
sized in the CLEM overlay (Fig. 5b). Between the cell–cell 
contacts, labels are detected (Fig. 5c), suggesting the good 
penetration of this FLIPPER-body. Some cells have regions 
with less label efficiency in fluorescence as well as in elec-
tron density (Fig. 5c). This suggests an irregular distribution 
of HER2 in the plasma membrane, which is in agreement 
with the previous reports (Chung et al. 2016).
Fig. 3  FLIPPER-body targets specific overexpressed EGFR. 
HEK293T expressing EGFR-GFP. a Detection of EGFR by GFP flu-
orescence, as well as by indirect labeling of EGFR with secondary 
antibodies conjugated to QD655. Note that QD655 are detected at the 
periphery of the cells, but not at cell–cell contact sites. b Detection 
of EGFR using FLIPPER-body (cartoon right). The FLIPPER-body 
labels uniquely the EGFR-GFP positive cells, including at the cell–
cell contact sites. DIC differential interference contrast, GFP GFP 
fluorescence, QD655 QD655 fluorescence, dTomato FLIPPER-body, 
merged GFP and label, EM ultrathin EM section. Bars LM 10  µm, 
EM 5 µm, EM zoom in 0.5 µm. High-resolution EM images are avail-
able via http://www.nanotomy.org
Fig. 4  FLIPPER-body reveals localization of endogenous EGFR. 
a EGFR on A431 cell was labeled using anti-EGFR and secondary 
IgG conjugated with QD655. Note that the QD655 labeling is mainly 
restricted to the periphery of the cell clusters. b EGFR is labeled with 
FLIPPER-body shown at the  top. The cell periphery as well as the 
cell–cell contact sites are labeled with fluorescence and black staining 
in EM. DIC differential interference contrast, QD655 QD655 fluores-
cence, dTomato FLIPPER-body. Bars LM 20 µm, EM 10 µm and EM 
zoom in 200 nm. High-resolution large-scale EM images are available 
via http://nanotomy.org
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Discussion
Genetically-encoded FLIPPER-bodies were created as an 
alternative for multiplex immuno-labeling with nanoparti-
cles for CLEM. Proof-of-concepts that the single-step nan-
obody-based labeling is more efficient and penetrates bet-
ter than traditional immuno-labeling using IgGs are given 
in examples of nuclear labeling as well as for endogenous 
plasma membrane receptor labeling, including in cell–cell 
contact sites. Importantly, this experimental result is a bet-
ter reflection of receptor localization that would be missed 
by traditional CLEM or EM antibody-based labeling strat-
egies, which does not label nuclear proteins or receptors 
at cell–cell contacts (see results above and Schnell et al. 
2012). Improved labeling with FLIPPER-bodies may be 
caused by (1) better penetration into dense structures as a 
result of their small size (~ 75 kDa) as compared to the size 
of IgG antibodies (~ 150 kDa) that are linked to nanopar-
ticles (Fig. 1a); (2) the FLIPPER-body requires a single-
labeling step, the signal is not enhanced by amplification 
in a second step, but all target-reaching FLIPPER-bodies 
will have label; and (3) FLIPPER-bodies are small pro-
teins, so it is a flexible molecule which might more eas-
ily reach the epitope in contrast to QDs or gold particles 
(Giepmans et al. 2005). Even compared to the bulky IgGs 
conjugated to a couple of small Alexa dyes, FLIPPER-
bodies can reach the epitope better.
The FLIPPER-body technology represents a versatile 
system that can be designed to bind to any possible target, 
and can be provided with any possible color or peroxidase 
by simple molecular cloning. FLIPPER-bodies are preferen-
tially as small as possible and easily produced and secreted 
in a production cell-line-like CHO cells. As nanobodies 
are single-chain-binding units, small, and to be generated 
against any possible target, the nanobody is currently the 
preferred binding unit. Moreover, given the versatility of 
nanobody applications (Beghein and Gettemans 2017) and 
recent establishment of a centralized nanobody database 
collection (ICAN; Zuo et al. 2017), the expansion of the 
FLIPPER-bodies has great promise. However, alternative 
small, single-domain-binding scaffolds capable of binding 
with high affinity to their target such as affibodies may also 
be employed in the FLIPPER-body technology (Helma et al. 
2015). Note that because of the genetic encoding, molecular 
biology tools easily will help to refine the FLIPPER-bodies, 
like the continuous improvements, we have seen for fluores-
cent proteins and genetically-encoded biosensors (Giepmans 
et al. 2006; Rodriguez et al. 2017). In addition, note that, 
like all plasmids or hybridomas, the FLIPPER-bodies can 
be shared free of charge within the scientific community, as 
opposed to antibodies. Our future studies will assess whether 
the FLIPPER-bodies can also be used in Tokuyasu-like 
immuno-EM (Webster et al. 2008) or EPON-section labe-
ling (Kuipers et al. 2015a) and might also be a generic tool 
for post-embedding labeling.
A limitation of peroxidase-based probes, like the FLIP-
PER-body is that in EM, labeling multiple targets cannot be 
distinguished, while with QDs, it is possible to distinguish 
multiple targets due to differences in shape (Giepmans et al. 
2005). One way of using multiple targets would be using 
multiple fluorescent colors and later layering the images to 
see where each target is localized. Another option for double 
labeling makes use of DAB with specific incorporated lan-
thanides detectable with an electron energy detector (Adams 
et al. 2016). In this case, after the first labeling Cerium-
DAB2, which is added and blocked, followed by the second 
label and black precipitates are formed with Lanthanum-
DAB2. The different lanthanides then can be distinguished. 
Similarly, X-ray detection may possibly be used to discrimi-
nate between certain Lanthanides-containing DAB precipi-
tates, which may be even multiplexed with gold particles or 
QDs (Scotuzzi et al. 2017).
In conclusion, FLIPPER-bodies have the potential to 
become a generic probe to identify proteins in CLEM with 
Fig. 5  Correlated microscopy of endogenous HER2. SkBr3 cells 
labeled and processed for CLEM. a HER2 detection with anti-HER2 
FLIPPER-body with dTomato fluorescence. In EM, a black substrate 
is surrounding the cells. b Overlap of the fluorescence and EM image 
resulting in the CLEM image. c Zoom in EM images shows the labe-
ling at the cells periphery and cell–cell contact sites (green zoom in). 
It is also noted that there is a heterogeneous distribution of the HER2 
labeling (blue zoom in). DIC differential interference contrast, LM 
dTomato fluorescence, EM ultrathin EM section. Bars LM 10  µm, 
EM 10 µm and EM zoom in 500 nm. High-resolution EM images are 
available via http://www.nanotomy.org
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significant benefits over existing immuno-EM using IgGs, 
most importantly in better access to the epitope.
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